Novel use of imatinib to treat mandibular fibrous dysplasia in Noonan’s syndrome11Presented as Goldman JW, Edwards S, Mody R, Jasty-Rao R. Novel use of imatinib in Noonan syndrome that presented as mandibular fibro-osseous dysplasia. American Society of Pediatric Hematology/Oncology Annual Conference. Poster presentation. Pittsburgh, Pennsylvania, 2022
Joshua W. Goldman, MD1*, Sean Edwards, MD, DDS2, Rajen Mody, MBBS, MS1, and Rama Jasty-Rao, MBBS1
Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI, USA 1
Department of Oral and Maxillofacial Surgery, University of Michigan Medical School, Ann Arbor, MI, USA 2
Corresponding author information:
Joshua Goldman, MD
1500 East Medical Center Drive
MPB 4202 SPC 5718
Ann Arbor, MI 48109
734-936-9814 (office)
734-232-8740 (fax)
josgoldm@med.umich.edu
Word count: Abstract (72), main text (688)
Figures submitted: 1
Running title: Imatinib to treat fibrous dysplasia
Keywords: fibrous dysplasia, Noonan syndrome, imatinib, PTPN11
Abbreviations utilized: